Amalia Issa
Chair, Department of Health Policy and Public Health
Founding Director, Program in Personalized Medicine & Targeted Therapeutics
Professor of Health Policy and Public Health
University of the Sciences
USA
Amalia M. Issa, PhD, MPH, FCPP, is an internationally recognized scientist in the field of personalized genomic medicine. She is currently professor and chair of the Department of Health Policy and Public Health at the University of the Sciences in Philadelphia, and founding director of the Program in Personalized Medicine and Targeted Therapeutics. She founded the program in 2001 as one of the first centers focused on pharmacogenomics and personalized medicine and their translation to healthcare delivery. She joined the university in 2011, and brought this research center with her.
Issa was among the first scientists to initiate translational research on the policy-relevant issues of pharmacogenomics. She developed a unique area of translational research in pharmacogenomics and personalized genomic medicine applications, and how they will be translated and integrated into healthcare delivery. Issa focuses on epidemiology/health services and molecular science, and leads an interdisciplinary team of scientists who seek to translate personalized genomic medicine research from the laboratory to the community.
Issa has numerous publications in the peer-reviewed literature on pharmacogenomics and personalized medicine, as well as in the areas of pharmacoepidemiology, clinical pharmacology, neuropharmacology, and drug safety. She serves on editorial boards and in leadership positions in several professional associations, and has received many awards for her work. A native of Montreal, she holds degrees from McGill University (PhD in neuroscience), the University of California, Los Angeles School of Public Health, and has completed fellowship training at Harvard Medical School.